Novel coronavirus pneumonia is a doomed year in the history of investment in 2020. The sudden outbreak of the new crown pneumonia has brought great crises to China and the global economy*tries and accelerated the reform of the capital market.

On March 1, the new securities law was formally implemented, creating conditions for the reform and innovation of the capital market.

Not long ago, the state passed the overall implementation plan for gem reform and pilot registration system, which is another major reform of the capital market after the first batch of science and technology innovation board enterprises went public in July last year, reflecting the state's support and attention to innovative enterprises representing the future economic direction under the current complex international and domestic economic environment.

Affected by the epidemic situation, medical and large-scale health listed companies have received unprecedented attention from the capital market*tries, such as masks, respirators, reagent testing, innovative drugs, and many stocks have constantly reached new highs.

The new crown epidemic not only has a profound impact on the economy, but also changes people's living habits and ways of thinking*e the goal of more people*e an important engine to drive China's economic growth in the future, from which some companies with great potential will be born* for the rapid development of these companies* pneumonia has been basically controlled in May. The operation of the economy and capital market is gradually returning to normal.

How to evaluate the impact of China's economy in the post epidemic period? How will big health, real estate and other industries develop? Is the valuation of a shares more attractive after the epidemic correction? Which sectors may have investment opportunities in the future?

At 8:00 p* economist, led the lecture on the second stage of wealth lecture in Dawan District, bringing you China's macroeconomic analysis and opportunity outlook. Huiyi capital partner Xu Wanning, biomedical R & D expert Tang Jian, chief strategist Hu Yu of Huaxun investment will also share and interact with you online to discuss: where are the investment opportunities in the post epidemic period?